Stock listing

Alterity Therapeutics Ltd.

Selected listing: ATH · ASX · AUD · AU

Alterity Therapeutics Ltd. (ASX:ATH), Health Technology. Latest release Oct 5, 2026: Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data…

ATH:ASXAUDAUUpdated October 2, 2026

Ticker: ASX:ATH
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: ASX
Currency: AUD

About Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd. is a public company listed on the Australian market under the ticker ATH. Alterity focuses on developing innovative therapies for neurodegenerative diseases.

Latest news from Alterity Therapeutics Ltd.

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

October 5, 2026

Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026

September 3, 2026

$4.2M Options Underwriting Agreement Executed

August 30, 2026

Appendix 4E and 2026 Annual Report

August 28, 2026

Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434

August 12, 2026

All Alterity Therapeutics Ltd. news →

Research Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd. company profile

View the public company page for Alterity Therapeutics Ltd. on 6ix.

Alterity Therapeutics Ltd. news

Read company news and market updates connected to Alterity Therapeutics Ltd..

Alterity Therapeutics Ltd. investor events

Find investor webinars, events, and replay context for Alterity Therapeutics Ltd..